Table 5.

Overall susceptibilities of organisms isolated from samples taken off after 48–72 h of admission

	Bacterial species
	No. susceptible/total number tested (%)
	K. pneumoniae	S. aureus	Pseudomonas spp.	Acinetobacter spp.	Enterobacter spp.	E. coli	MRSA	Coagulase negative Staph	Viridans streptococcus	Enterococcus
Amikacin (30 µg)	3/3 (100)	0/1 (0)	2/5 (40)	4/6 (66.67)	2/3 (67)	1/1 (100)	–	–	–	–
Augmentin (20/10 µg)	1/10 (10)	–	–	0/2 (0)	0/4 (0)	0/1 (0)	–	–	–	–
Ampicillin (10 µg)	0/11 (0)	–	–	0/1 (0)	0/4 (0)	–	–	–	–	1/1 (100)
Cefotaxime (30 µg)	1/4 (25)	–	–	0/2 (0)	–	–	–	–	–	–
Cefuroxime (30 µg)	1/11 (9.10)	–	–	–	0/4 (0)	–	–	–	–	–
Ceftazidime (30 µg)	1/9 (11.11)	0/1 (0)	2/5 (40)	2/10 (20.00)	0/4 (0)	0/1 (0)	–	–	–	–
Ceftriaxone (30 µg)	1/8 (12.50)	1/1 (100)	–	0/3 (0)	0/4 (0)	0/1 (0)	–	–	–	–
Cefepime (30 µg)	–	–	1/4 (25)	1/5 (20)	–	–	–	–	–	–
Ciprofloxacin (5 µg)	3/9 (33.33)	3/6 (50)	3/6 (50)	1/8 (12.05)	1/4 (25)	0/1 (0)	1/1 (100)	0/3 (0)	–	0/1 (0)
Chloramphenicol (30 µg)	2/9 (22.22)	3/4 (75)	–	0/2 (0)	0/4 (0)	–	0/1 (0)	0/1 (0)	1/1 (100)	0/1 (0)
Co-trimoxazole (1.25/23.5 µg)	0/10 (0)	0/4 (0)	–	0/8 (0)	0/5 (0)	0/1 (0)	0/1 (0)	0/2 (0)	–	–
Erythromycin (15 µg)	–	1/6 (16.67)	–	–	0/2 (0)	–	0/1 (0)	0/2 (0)	1/1 (100)	–
Oxacillin (1 µg)	–	1/4 (25)	–	–	2/2 (100)	–	0/1 (0)	1/2 (50)	–	–
Tetracycline (30 µg)	0/1 (0)	2/3 (66.67)	0/1 (0)	0/1 (0)	–	–	–	1/1 (100)	–	0/1 (0)
Penicillin G (10 µg)		1/4 (25)	–	–	0/2 (0)	–	–	0/2 (0)	0/1 (0)	–
Gentamicin (10 µg)	2/10 (20.00)	4/6 (66.67)	3/6 (50)	1/9 (11.11)	0/5 (0)	0/1 (0)	1/1 (100)	0/3 (0)	–	1/1 (100)
Imipenem (10 µg)	5/8 (62.5)	1/1 (100)	4/5 (80)	5/6 (83)	2/2 (100)	1/1 (100)	–	–	–	–
Piperacillin tazobactam (100/10 µg)	4/4 (100)	–	3/6 (50)	5/9 (55.56)	2/4 (50)	–	–	–	–	–
Meropenem (10 µg)	0/2 (0)		1/1 (100)	2/4 (50.00)	3/3 (100)	–	–	–	–	–
Vancomycin (30 µg)	–	5/6 (83.3)	–	–	–	–	1/1 (100)	2/2 (100)	1/1 (100)	1/1 (100)